MYNZ: Mainz Biomed N.V

MYNZ新闻

• 11:38 Mainz Biomed任命新董事长并更名为Quantum Cyber
• 11:37 Mainz Biomed appoints new chairman, rebrands as Quantum Cyber
• 12:37 Mainz Biomed secures $6 million funding, shifts focus to pancreatic cancer
• 22:58 Mainz Biomed通过场内股票发行筹集215万美元
• 22:57 Mainz Biomed raises $2.15 million through at-the-market share offering
• 08:35 Mainz Biomed Update: Early Detection Test For Pancreatic Cancer Demonstrates Never Before Seen Results, Company Ready To Launch ColoAlert In Switzerland - Mainz Biomed (NASDAQ:MYNZ)
• 12:05 Mainz Biomed’s colorectal cancer test receives Swiss regulatory approval
• 12:32 Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
• 00:12 Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
• 16:46 Mainz Biomed stock plunges to 52-week low of $2.18 amid market challenges
• 10:34 Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Affimed (NASDAQ:AFMD), Abpro Hldgs (NASDAQ:ABP)
• 12:06 Mainz Biomed to update on CRC screening study by end of summer